Cresilon Closes $25 Million In Series A-4 Financing To Accelerate Global Expansion And Bring Revolutionary Hemostatic Gel To Human Health Market
Amount Raised
$25 Million
Round Type
Series A
BrooklynBiotechnologyDescription
Cresilon, Inc., the Brooklyn-based biotechnology company developing and manufacturing innovative hemostatic medical device technologies, today announced the successful completion of a $25 million Series A-4 financing round. The financing will support the company's efforts to aggressively accelerate its global expansion plan and bring its revolutionary hemostatic gel to the human health market.
Quick answer
Cresilon raised $25 Million in a Series A round, dated October 27, 2022. Cresilon is based in Brooklyn, New York, United States.
- How much did Cresilon raise?
- Cresilon raised $25 Million in a Series A round on October 27, 2022.
- What does Cresilon do?
- Cresilon, Inc. is a privately held medical device company headquartered in Brooklyn, New York, specializing in hemostatic technologies designed to improve wound care and elevate the standard of medical treatment.
- Where is Cresilon based and how big is it?
- Cresilon is based in Brooklyn, New York, United States. Fundz records about 88 employees.
- Who are the decision-makers at Cresilon?
- Fundz holds 3 contacts at Cresilon, including the Vice President, Technology (Research & Development and Manufacturing Technology). Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Cresilon that raised within 45 days of this round, from Fundz verified event records.
- Membrion raised $7M on December 9, 2022.
- Launchpad Therapeutics raised $10M on December 9, 2022.
- Aer Therapeutics raised $16M on December 9, 2022.
- Eigen raised an undisclosed amount (Funding Round) on December 8, 2022.
- Ubie raised an undisclosed amount (Series C) on December 8, 2022.
- Vevo Therapeutics raised $12M (Seed) on December 8, 2022.
Who to call at Cresilon, and when
A new round usually means Cresilon is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cresilon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cresilon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cresilon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cresilon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCresilon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.